We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF

213 hedge funds and large institutions have $528M invested in ARK Genomic Revolution ETF in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 69 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $482M → $528M (+$45.6M)

6% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 33

0% less funds holding

Funds holding: 214213 (-1)

7% less call options, than puts

Call options by funds: $107M | Put options by funds: $116M

3.25% less ownership

Funds ownership: 53.18%49.93% (-3.2%)

43% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 69

Holders
213
Holders Change
-1
Holders Change %
-0.47%
% of All Funds
2.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
39
Reduced
69
Closed
33
Calls
$107M
Puts
$116M
Net Calls
-$8.28M
Net Calls Change
-$21M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
26
Cresset Asset Management
Illinois
$1.76M +$15.6K +714 +1%
Baird Financial Group
27
Baird Financial Group
Wisconsin
$1.75M +$706K +32,221 +81%
BPA
28
Beacon Pointe Advisors
California
$1.71M +$35.2K +1,607 +2%
AI
29
Atom Investors
Texas
$1.66M -$279K -12,742 -16%
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$1.62M +$1.28M +58,421 +709%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$1.49M +$106K +4,855 +9%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$1.4M -$1.39M -63,474 -52%
TRCT
33
Tower Research Capital (TRC)
New York
$1.4M +$865K +39,474 +221%
BCM
34
Brookstone Capital Management
Illinois
$1.28M -$57.6K -2,628 -5%
SA
35
Sanctuary Advisors
Indiana
$1.22M -$682K -31,144 -38%
Squarepoint
36
Squarepoint
New York
$1.21M -$407K -18,581 -27%
Stifel Financial
37
Stifel Financial
Missouri
$1.21M +$85.2K +3,889 +8%
MCP
38
Militia Capital Partners
Nevada
$1.18M +$1.06M +48,600 New
Envestnet Asset Management
39
Envestnet Asset Management
Illinois
$1.16M -$495K -22,593 -32%
Wealthfront Advisers
40
Wealthfront Advisers
California
$1.1M -$11K -504 -1%
SB
41
SIG Brokerage
New York
$1.06M
JIP
42
Jaffetilchin Investment Partners
Florida
$994K +$895K +40,822 New
Simplex Trading
43
Simplex Trading
Illinois
$936K +$842K +38,448 New
Wolverine Trading
44
Wolverine Trading
Illinois
$933K +$329K +15,032 +64%
PWM
45
Perigon Wealth Management
California
$920K +$98K +4,471 +13%
Carson Wealth (CWM LLC)
46
Carson Wealth (CWM LLC)
Nebraska
$917K -$10.1K -462 -1%
CGA
47
Crescent Grove Advisors
Illinois
$891K +$45.1K +2,056 +6%
DP
48
DDD Partners
Washington
$880K +$8.79K +401 +1%
PFS
49
Prospera Financial Services
Texas
$873K -$24.3K -1,110 -3%
Parallax Volatility Advisers
50
Parallax Volatility Advisers
California
$871K -$1.59M -72,544 -67%

ARKG Hedge Fund Activity: Q2 2025 in Review

213 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2025, worth a combined $528M — up 9.5% from $482M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ARKG positions and 33 closed out — a net gain of 2 holders — while 39 added to existing stakes and 69 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $20.2M. The largest seller was Citigroup, cutting an estimated $41.4M.

  • 213 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2025, down from 214 in Q1 2025.
  • Funds reported $528M of ARK Genomic Revolution ETF stock for Q2 2025, up 9.5% quarter-over-quarter.
  • 35 funds opened new ARK Genomic Revolution ETF positions in Q2 2025 and 33 closed out, a net change of +2 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2025 was JP Morgan Chase, an estimated $20.2M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2025 was Citigroup, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2025.